Listed

Can-Fite BioPharma Ltd.

CANFNYSECIK 1536196HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$5.5m, FY2025
Shareholders' equity$5.6m, FY2025
Line itemUnitperiod not labelled2015-12-31period not labelled2016-12-31FY20172017-12-31FY20182018-12-31FY20192019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$m16.9Cash and equivalents, period not labelled, at 2015-12-31$16.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2019-03-29, accession 0001213900-19-005251.Report this figure8.1Cash and equivalents, period not labelled, at 2016-12-31$8.1m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2020-03-27, accession 0001213900-20-007682.Report this figure3.5Cash and equivalents, FY2017, at 2017-12-31$3.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2021-03-25, accession 0001213900-21-017630.Report this figure3.6Cash and equivalents, FY2018, at 2018-12-31$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2021-03-25, accession 0001213900-21-017630.Report this figure2.7Cash and equivalents, FY2019, at 2019-12-31$2.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2021-03-25, accession 0001213900-21-017630.Report this figure8.3Cash and equivalents, FY2020, at 2020-12-31$8.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2022-03-24, accession 0001213900-22-014672.Report this figure4.4Cash and equivalents, FY2021, at 2021-12-31$4.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2023-03-30, accession 0001213900-23-024298.Report this figure3.0Cash and equivalents, FY2022, at 2022-12-31$3.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2024-03-28, accession 0001213900-24-026947.Report this figure4.3Cash and equivalents, FY2023, at 2023-12-31$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2025-04-14, accession 0001213900-25-031298.Report this figure4.8Cash and equivalents, FY2024, at 2024-12-31$4.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure5.5Cash and equivalents, FY2025, at 2025-12-31$5.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure
Current assets$mnot reportednot reported6.7Current assets, FY2017, at 2017-12-31$6.7m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2019-03-29, accession 0001213900-19-005251.Report this figure7.9Current assets, FY2018, at 2018-12-31$7.9m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2020-03-27, accession 0001213900-20-007682.Report this figure7.1Current assets, FY2019, at 2019-12-31$7.1m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2021-03-25, accession 0001213900-21-017630.Report this figure9.4Current assets, FY2020, at 2020-12-31$9.4m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2022-03-24, accession 0001213900-22-014672.Report this figure20.1Current assets, FY2021, at 2021-12-31$20.1m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2023-03-30, accession 0001213900-23-024298.Report this figure9.2Current assets, FY2022, at 2022-12-31$9.2m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2024-03-28, accession 0001213900-24-026947.Report this figure9.9Current assets, FY2023, at 2023-12-31$9.9m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2025-04-14, accession 0001213900-25-031298.Report this figure9.0Current assets, FY2024, at 2024-12-31$9.0m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure9.4Current assets, FY2025, at 2025-12-31$9.4m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure
Total assets$mnot reportednot reported7.6Total assets, FY2017, at 2017-12-31$7.6m. XBRL concept ifrs-full:Assets. 20-F filed 2019-03-29, accession 0001213900-19-005251.Report this figure8.0Total assets, FY2018, at 2018-12-31$8.0m. XBRL concept ifrs-full:Assets. 20-F filed 2020-03-27, accession 0001213900-20-007682.Report this figure8.2Total assets, FY2019, at 2019-12-31$8.2m. XBRL concept us-gaap:Assets. 20-F filed 2021-03-25, accession 0001213900-21-017630.Report this figure9.5Total assets, FY2020, at 2020-12-31$9.5m. XBRL concept us-gaap:Assets. 20-F filed 2022-03-24, accession 0001213900-22-014672.Report this figure20.3Total assets, FY2021, at 2021-12-31$20.3m. XBRL concept us-gaap:Assets. 20-F filed 2023-03-30, accession 0001213900-23-024298.Report this figure9.3Total assets, FY2022, at 2022-12-31$9.3m. XBRL concept us-gaap:Assets. 20-F filed 2024-03-28, accession 0001213900-24-026947.Report this figure10.0Total assets, FY2023, at 2023-12-31$10.0m. XBRL concept us-gaap:Assets. 20-F filed 2025-04-14, accession 0001213900-25-031298.Report this figure9.1Total assets, FY2024, at 2024-12-31$9.1m. XBRL concept us-gaap:Assets. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure9.5Total assets, FY2025, at 2025-12-31$9.5m. XBRL concept us-gaap:Assets. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure
Current liabilities$mnot reportednot reported1.8Current liabilities, FY2017, at 2017-12-31$1.8m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2019-03-29, accession 0001213900-19-005251.Report this figure3.1Current liabilities, FY2018, at 2018-12-31$3.1m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2020-03-27, accession 0001213900-20-007682.Report this figure3.3Current liabilities, FY2019, at 2019-12-31$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2021-03-25, accession 0001213900-21-017630.Report this figure1.3Current liabilities, FY2020, at 2020-12-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2022-03-24, accession 0001213900-22-014672.Report this figure2.7Current liabilities, FY2021, at 2021-12-31$2.7m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2023-03-30, accession 0001213900-23-024298.Report this figure2.5Current liabilities, FY2022, at 2022-12-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2024-03-28, accession 0001213900-24-026947.Report this figure2.0Current liabilities, FY2023, at 2023-12-31$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2025-04-14, accession 0001213900-25-031298.Report this figure2.1Current liabilities, FY2024, at 2024-12-31$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure2.7Current liabilities, FY2025, at 2025-12-31$2.7m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure
Shareholders' equity$m13.9Shareholders' equity, period not labelled, at 2015-12-31$13.9m. XBRL concept ifrs-full:Equity. 20-F filed 2019-03-29, accession 0001213900-19-005251.Report this figure6.0Shareholders' equity, period not labelled, at 2016-12-31$6.0m. XBRL concept ifrs-full:Equity. 20-F filed 2020-03-27, accession 0001213900-20-007682.Report this figure3.0Shareholders' equity, FY2017, at 2017-12-31$3.0m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2021-03-25, accession 0001213900-21-017630.Report this figure3.0Shareholders' equity, FY2018, at 2018-12-31$3.0m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2022-03-24, accession 0001213900-22-014672.Report this figure2.4Shareholders' equity, FY2019, at 2019-12-31$2.4m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2023-03-30, accession 0001213900-23-024298.Report this figure6.1Shareholders' equity, FY2020, at 2020-12-31$6.1m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2024-03-28, accession 0001213900-24-026947.Report this figure14.4Shareholders' equity, FY2021, at 2021-12-31$14.4m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2025-04-14, accession 0001213900-25-031298.Report this figure4.5Shareholders' equity, FY2022, at 2022-12-31$4.5m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure6.2Shareholders' equity, FY2023, at 2023-12-31$6.2m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure5.4Shareholders' equity, FY2024, at 2024-12-31$5.4m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure5.6Shareholders' equity, FY2025, at 2025-12-31$5.6m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-03-26, accession 0001213900-26-034447.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.